We are live on ! Find out more
IVM

InterWest Venture Management Portfolio holdings

AUM $20.6M
1-Year Est. Return 48.5%
This Fund
S&P 500
This Quarter Est. Return
-10.75%
1 Year Est. Return
+48.5%
3 Year Est. Return
-57.65%
5 Year Est. Return
-76.52%
10 Year Est. Return
AUM
$237M
AUM Growth
-$55.1M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
99.99%
Holding
11
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSRO
1
DELISTED
TESARO, Inc.
TSRO
$116M 48.67%
2,021,738
GKOS icon
2
Glaukos
GKOS
$8.72B
$31.4M 13.23%
1,018,362
MGNX icon
3
MacroGenics
MGNX
$238M
$27M 11.39%
1,074,316
VERO
4
DELISTED
Venus Concept
VERO
$20.9M 8.81%
1,356
EIGR
5
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$15.8M 6.64%
53,320
HIND
6
Vyome Holdings
HIND
$14M
0
AGTC
7
DELISTED
Applied Genetic Technologies Corporation
AGTC
$5.61M 2.36%
1,455,904
CDTX
8
DELISTED
Cidara Therapeutics
CDTX
$5.43M 2.29%
67,841
IVTY
9
DELISTED
Invuity, Inc
IVTY
$4.16M 1.75%
1,080,272
KALV
10
DELISTED
KalVista Pharmaceuticals
KALV
$3.13M 1.32%
329,942
XENE icon
11
Xenon Pharmaceuticals
XENE
$6.26B
$23K 0.01%
8,293

Similar funds

InterWest Venture Management's Q1 2018 Portfolio in Review

As of Q1 2018, InterWest Venture Management held 11 positions worth $237M, down 19% from $292M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2018: portfolio turnover was 0%. InterWest Venture Management opened no new positions and made no exits, leaving the 11-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • InterWest Venture Management's ten largest holdings make up 100% of its $237M portfolio in Q1 2018.
  • InterWest Venture Management opened 0 new positions and closed 0 in Q1 2018.
  • InterWest Venture Management's portfolio value fell 19% quarter-over-quarter to $237M.

Based on InterWest Venture Management's 13F filing for Q1 2018, filed 5 Apr 2018.